# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!


Ovarian cancer

Cancer, Ovarian
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 2581-2590 of 2727 results.
A Study of ABBV-428, an Immunotherapy, in Subjects With Advanced Solid Tumors
Status: Completed
Last Changed: Jul 20, 2020
First Received: Nov 04, 2016
Disease(s): Advanced Solid Tumors Cancer
Intervention(s): ABBV-428, Nivolumab
Locations: HonorHealth Research Institute - Pima /ID# 155461, Scottsdale, Arizona, United States
UC Davis Comprehensive Cancer Center - Main /ID# 154439, Sacramento, California, United States
University of Chicago /ID# 154440, Chicago, Illinois, United States
Fox Chase Cancer Center /ID# 170665, Philadelphia, Pennsylvania, United States
Greenville Hospital System /ID# 154437, Greenville, South Carolina, United States
... and 11 other locations.
Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)
Status: Terminated
Last Changed: May 03, 2013
First Received: Aug 05, 2004
Disease(s): Cancer
Intervention(s): mycophenolate mofetil, placebo
Locations: City of Hope Comprehensive Cancer Center, Duarte, California, United States
Stanford Cancer Center, Stanford, California, United States
University of Florida Shands Cancer Center, Gainesville, Florida, United States
University of Chicago Cancer Research Center, Chicago, Illinois, United States
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
... and 12 other locations.
A Phase 1 Study of Single Agent Veliparib in Japanese Subjects With Advanced Solid Tumors
Status: Completed
Last Changed: May 07, 2018
First Received: Aug 07, 2014
Disease(s): Advanced Solid Tumors
Intervention(s): veliparib (ABT-888)
Locations: Site Reference ID/Investigator# 128056, Hidaka-shi, Japan
Site Reference ID/Investigator# 129976, Hyogo, Japan
Site Reference ID/Investigator# 128057, Tokyo, Japan
A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies
Status: Completed
Last Changed: Sep 01, 2020
First Received: Aug 07, 2017
Disease(s): Advanced Malignancies
Intervention(s): INCAGN01949, Nivolumab, Ipilimumab, INCAGN01949
Locations: The University of Alabama Birmingham (UAB), Birmingham, Alabama, United States
Scottsdale Healthcare Hospitals DBA HonorHealth, Scottsdale, Arizona, United States
The Angeles Clinic and Research Institute, Los Angeles, California, United States
Mount Sinai Medical Center of Florida, Inc., Miami, Florida, United States
University of Michigan, Ann Arbor, Michigan, United States
... and 11 other locations.
A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors
Status: Completed
Last Changed: Jul 15, 2016
First Received: Mar 30, 2011
Disease(s): Locally Advanced Malignant Neoplasm, Malignant Solid Tumour
Intervention(s): ALT-836 in combination with gemcitabine
Locations: Emory University, Winship Cancer Institute, Atlanta, Georgia, United States
University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States
University of Rochester Medical Center, James P. Wilmot Cancer Center, Rochester, New York, United States
Carolinas Hematology-Oncology Associates, Charlotte, North Carolina, United States
Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment
Status: Terminated
Last Changed: Feb 20, 2009
First Received: Jan 03, 2008
Disease(s): Malignant Epithelial Mesothelioma, Adenocarcinoma of the Pancreas, Carcinoma, Non-Small-Cell Lung, Adenocarcinoma of the Ovaries
Intervention(s): CRS-207, Live-attenuated Listeria monocytogenes expressing human Mesothelin
Locations: The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland, United States
National Cancer Institute, NCI, Bethesda, Maryland, United States
University of Pennsylvania Abramson Family Cancer Research Center, Philadelphia, Pennsylvania, United States
Hadassah Hebrew University Medical Center, Jerusalem, Israel
Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing Cancers
Status: Recruiting
Last Changed: Oct 27, 2020
First Received: Sep 08, 2016
Disease(s): HER2-expressing Cancers
Intervention(s): ZW25 (Zanidatamab), Paclitaxel, Capecitabine, Vinorelbine
Locations: University of Alabama, Birmingham, Alabama, United States
USC/Norris Cancer Center, Los Angeles, California, United States
Hoag Family Cancer Institute, Newport Beach, California, United States
University of Colorado Cancer Center, Aurora, Colorado, United States
Rush University Medical Center, Chicago, Illinois, United States
... and 13 other locations.
Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Status: Terminated
Last Changed: Feb 17, 2020
First Received: Mar 17, 2016
Disease(s): Solid Tumors
Intervention(s): INCB057643, INCB057643, Gemcitabine, Paclitaxel, Rucaparib, Abiraterone, Ruxolitinib, Azacitidine
Locations: University of Alabama, Birmingham, Alabama, United States
University of California, La Jolla, California, United States
Sarah Cannon Research Institute at Health One, Denver, Colorado, United States
Yale University, New Haven, Connecticut, United States
Sylvester Comprehensive Cancer Center, Miami, Florida, United States
... and 14 other locations.
Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer Patients
Status: Unknown status
Last Changed: Nov 07, 2017
First Received: Sep 13, 2013
Disease(s): Small Cell Lung Carcinoma, Non Small Cell Lung Carcinoma, Irinotecan Sensitive Cancers
Intervention(s): Carfilzomib, Irinotecan
Locations: Cancer Treatment Centers of America, Western Regional Medical Center, Goodyear, Arizona, United States
Cedars-Sinai Medical Center, Los Angeles, California, United States
UCLA, Santa Monica, California, United States
University of Kentucky Markey Cancer Center, Lexington, Kentucky, United States
Norton Cancer Institute, Louisville, Kentucky, United States
... and 6 other locations.
A Study to Evaluate the Safety and Tolerability of ETC-1922159 in Advanced Solid Tumours
Status: Recruiting
Last Changed: Sep 22, 2020
First Received: Aug 13, 2015
Disease(s): Solid Tumors
Intervention(s): ETC-1922159, Pembrolizumab
Locations: University of Colorado Hospital Anschutz Cancer Pavilion, 1665 Aurora Court, Aurora, Colorado, United States
Washington University School of Medicine, Siteman Cancer Center, 4921 Parkview Place, Saint Louis, Missouri, United States
Duke University Medical Center, Duke Cancer Center, 20 Duke Medicine Circle, Durham, North Carolina, United States
The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 455, Houston, Texas, United States
National University Hospital, 1E Kent Ridge Road, NUHS Tower Block, Level 7, Singapore, Singapore
... and 2 other locations.